Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for leukemia, chronic lymphocytic, susceptibility to, 5 has been reported in the published literature.
No clinical trials have been registered for leukemia, chronic lymphocytic, susceptibility to, 5.
16 publications have been identified in PubMed for leukemia, chronic lymphocytic, susceptibility to, 5. Research spans Epidemiology / Natural History (31%), Review / Meta-Analysis (19%), and Basic Science / Preclinical (19%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 5 | 31% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:55 PM UTC
Online Mendelian Inheritance in Man
Research summaries |
3 |
19% |
Laboratory research | 3 | 19% |
Patient case studies | 2 | 13% |
Testing and diagnosis research | 1 | 6% |
Clinical study results | 1 | 6% |
New treatment approaches | 1 | 6% |
Pasca S (2026). [PMID: 41708630](https://pubmed.ncbi.nlm.nih.gov/41708630/). *Nat Commun*. [Basic Science / Preclinical]
DiNardo CD (2026). [PMID: 41686515](https://pubmed.ncbi.nlm.nih.gov/41686515/). *Cancer*. [Epidemiology / Natural History]
Haj D (2026). [PMID: 41777646](https://pubmed.ncbi.nlm.nih.gov/41777646/). *Front Oncol*. [Case Report / Case Series]
Islam MS (2026). [PMID: 41866418](https://pubmed.ncbi.nlm.nih.gov/41866418/). *Sci Rep*. [Diagnostic / Biomarker]
Antonucci L (2026). [PMID: 41564125](https://pubmed.ncbi.nlm.nih.gov/41564125/). *Proc Natl Acad Sci U S A*. [Gene Therapy / Novel Therapeutics]
Cabrera-Serrano AJ (2025). [PMID: 40902075](https://pubmed.ncbi.nlm.nih.gov/40902075/). *Blood Adv*. [Review / Meta-Analysis]
Gilene S (2025). [PMID: 39864275](https://pubmed.ncbi.nlm.nih.gov/39864275/). *Cancer Genet*. [Case Report / Case Series]
Hubbard AK (2025). [PMID: 40305105](https://pubmed.ncbi.nlm.nih.gov/40305105/). *Cancer Res*. [Basic Science / Preclinical]
Kalicińska E (2025). [PMID: 39866935](https://pubmed.ncbi.nlm.nih.gov/39866935/). *EJHaem*. [Epidemiology / Natural History]
Mertowska P (2025). [PMID: 40062898](https://pubmed.ncbi.nlm.nih.gov/40062898/). *Pol Arch Intern Med*. [Basic Science / Preclinical]